Orthobiologics Market worth 6.06 Billion USD by 2022 - PowerPoint PPT Presentation


PPT – Orthobiologics Market worth 6.06 Billion USD by 2022 PowerPoint presentation | free to download - id: 8827e8-MTgzN


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Orthobiologics Market worth 6.06 Billion USD by 2022


Orthobiologics Market worth 6.06 Billion USD by 2022 – PowerPoint PPT presentation

Number of Views:17
Slides: 7
Provided by: swapnil9696


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Orthobiologics Market worth 6.06 Billion USD by 2022

MarketsandMarkets Presents
  • Orthobiologics Market 
  •  - Global Forecasts to 2022

  • The global orthobiologics market is projected to
    reach USD 6.06 Billion by 2022 from USD 4.66
    Billion in 2017, at a CAGR of 5.4 during the
    forecast period. Factors such as rising burden of
    orthopedic injuries increasing incidence of
    sports injuries and road accidents increasing
    incidence of spinal fusion surgeries risk
    factors associated with increasing aging
    population, obesity rate, high incidence of
    musculoskeletal disorders and growing patient
    preference for minimally invasive procedures are
    driving the orthobiologics market.
  • This report broadly segments the orthobiologics
    market into product, application, and end user.
    On the basis of product, the market is
    categorized into allografts, synthetic
    orthobiologics, PRP, BMAC, DBM, BMP, and
    viscosupplementation products. In 2017, the
    viscosupplementation products segment is expected
    to account for the largest share of the market.
    The large share of this segment can be attributed
    to the increasing incidence of osteoarthritis of
    the knee and hip joints among the baby boomer
    population and lower cost of viscosupplementations

ts/orthobiologics-market-162747970.html Based
on application, the market is segmented into
fracture recovery, osteoarthritis degenerative
arthritis, spinal fusion, soft-tissue injuries,
and maxillofacial dental applications. The
osteoarthritis degenerative arthritis segment
is estimated to command the largest share of the
global orthobiologics market in 2017. The large
share of this segment is mainly due to factors
such as the significant rise in target patient
population across major markets, rising public
awareness related to clinical side effects
associated with oral medications for pain
  • On the basis of end user, the market is segmented
    hospitals, orthopedic clinics, and ambulatory
    care centers research academic institutes and
    dental clinics and facilities. The hospitals,
    orthopedic clinics, and ambulatory care centers
    segment is poised to grow at the fastest rate
    during the forecast period. This can be
    attributed to the growing geriatric population
    (coupled with the increasing number of spinal
    fusion surgeries performed) road accident
    injuries and bone fractures growing prevalence
    of spinal disorders and growing awareness of
  • The report covers the orthobiologics market
    across four major geographies, namely, North
    America, Europe, Asia Pacific, and the Rest of
    the World (RoW). North America is expected to
    command the largest share of the market in 2017
    due to the increasing incidence of spinal
    disorders, rising geriatric and obese population,
    growing preference for minimally invasive
    procedures, and growing physician and patient
    awareness about newly introduced treatment
    procedures and technologies. However, Asia
    Pacific is expected to register the highest
    growth rate during the forecast period. The
    presence of a large geriatric and target patient
    population, high incidence of osteoarthritis and
    obesity, increasing government spending on
    healthcare, and improving healthcare
    infrastructure are some of the major factors
    driving the growth of the Asia Pacific
    orthobiologics market.

Contact Us
  • Mr. Rohan Markets and Markets UNIT no 802, Tower
    no. 7, SEZ Magarpatta city, Hadapsar Pune,
    Maharashtra 411013, India 1-888-600-6441 Email
  • MarketsandMarkets Blog
  • http//www.linkedin.com/company/marketsandmarkets
  • http//twitter.com/marketsmarkets

About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.
About PowerShow.com